Phibro Animal Health Corp (PAHC) Stock Analysis
Verdict: WATCH (do not buy)
Operational excellence and earnings beats are overshadowed by aggressive insider selling and a precarious debt-to-equity ratio of 2.18.
Investment score: 42/100
Analysis as of
Is Phibro Animal Health Corp stock worth reviewing? The TradeMates thesis
The model views PAHC as a 'falling knife' where strong trailing earnings are invalidated by aggressive insider selling and a deteriorating balance sheet.
7-factor investment score
- Valuation: 65/100 (weight 20%)
- Financial Health: 35/100 (weight 15%)
- Technical Momentum: 15/100 (weight 15%)
- Earnings Quality: 85/100 (weight 15%)
- Insider Sentiment: 10/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 40/100 (weight 15%)
Phibro Animal Health Corp opportunities and risks
What speaks for PAHC
- Undervaluation relative to historical means
What speaks against PAHC
- Excessive Leverage (Debt/Equity 2.18)
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| PAHC | 12.1x | 0.8x | 8.0x | 32.5% | 6.3% | 1.1% |
| AMLX | n/a | 0.0x | n/a | 0.0% | 0.0% | -10.9% |
| MBX | n/a | 0.0x | n/a | 0.0% | 0.0% | -7.7% |
| SEPN | n/a | 18.7x | n/a | 99.4% | -49.9% | 7.9% |
| MAZE | n/a | 67.2x | n/a | 92.0% | -612.7% | -9.1% |
| HROW | n/a | 4.6x | 35.8x | 74.1% | -5.6% | 1.2% |
| Peer median | n/a | 4.6x | n/a | 74.1% | -5.6% | -7.7% |
Frequently asked questions about Phibro Animal Health Corp (PAHC)
Is PAHC stock a good investment?
The TradeMates model rates Phibro Animal Health Corp as WATCH (do not buy) with an investment score of 42/100. The model views PAHC as a 'falling knife' where strong trailing earnings are invalidated by aggressive insider selling and a deteriorating balance sheet. This is algorithmic model output, not personal investment advice.
Is PAHC stock a buy?
The TradeMates model verdict for PAHC is WATCH (do not buy) with an investment score of 42/100. Treat this as a model signal to review, not a personal buy recommendation.